A STUDY OF TREATMENT RESULTS OF THE CANCER OF THE EYE FOLLOWING COMBINATION OF TREATMENT METHODS
Not Applicable
- Conditions
- Health Condition 1: C692- Malignant neoplasm of retina
- Registration Number
- CTRI/2022/10/046740
- Lead Sponsor
- DR RAJENDRA PRASAD CENTRE FOR OPHTHALMIC SCIENCES AIIMS NEW DELHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CASES DIAGNOSED WITH
1.IRSS STAGE 2: PATIENTS WHO UNDERWENT ENUCLEATION BUT HAVE MICROSCOPIC RESIDUAL DISEASE (THE PATIENT WITH INVOLVEMENT OF THE OPTIC NERVE TO THE TRANSECTION LINE AND THOSE WITH MICROSCOPIC TRANS-SCLERAL INVASION ON HISTOPATHOLOGY
2. IRSS STAGE 3: PATIENTS WITH REGIONAL EXTENSION
3A: PATIENTS WITH OVERT ORBITAL
DISEASE
3B: PATIENT WITH PREAURICULAR OR
CERVICAL LYMPH NODE EXTENSION
3. IRSS STAGE 4: PATIENTS WITH HAEMATOGENOUS
METASTASES NOT INVOLVING THE CNS
(STAGE 4A)
AND THOSE WITH CNS DISEASE (STAGE
4B)
Exclusion Criteria
IRSS STAGE 0 AND 1 RETINOBLASTOMA
PATIENTS NOT WILLING FOR TREATMENT
PATIENTS NOT WILLING FOR FOLLOW-UP
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To study the treatment outcomes of extraocular retinoblastoma following multimodal therapy. <br/ ><br>2. To study the adverse effects of treatment <br/ ><br>Timepoint: Outcome will be assessed at baseline, 3 months , 6 months, 12 months, 18 months
- Secondary Outcome Measures
Name Time Method To assess the risk factors associated with extraocular retinoblastomaTimepoint: 1.5YEARS